|
1
|
Elder DE, Massi D, Scolyer RA and Willemze
R: Basal cell carcinoma. In: WHO Classification of Skin Tumors. 4th
edition. International Agency for Research on Cancer, Lyon, France,
pp26-34, 2018.
|
|
2
|
Bichakjian CK, Olencki T, Aasi SZ, Alam M,
Andersen JS, Berg D, Bowen GM, Cheney RT, Daniels GA, Glass LF, et
al: Basal cell skin cancer, version 1.2016, NCCN clinical practice
guidelines in oncology. J Natl Compr Canc Netw. 14:574–597.
2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ciążyńska M, Sławińska M,
Kamińska-Winciorek G, Lange D, Lewandowski B, Reich A, Pabianek M,
Szczepaniak K, Hankiewicz A, Ułańska M, et al: Clinical and
epidemiological analysis of basosquamous carcinoma: Results of the
multicenter study. Sci Rep. 10(18475)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Akay BN, Saral S, Heper AO, Erdem C and
Rosendahl C: Basosquamous carcinoma: Dermoscopic clues to
diagnosis. J Dermatol. 44:127–134. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Giacomel J, Lallas A, Argenziano G,
Reggiani C, Piana S, Apalla Z, Ferrara G, Moscarella E, Longo C and
Zalaudek I: Dermoscopy of basosquamous carcinoma. Br J Dermatol.
169:358–364. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Alam M, Desai S, Nodzenski M, Dubina M,
Kim N, Martini M, Fife D, Reid D, Pirigyi M, Poon E, et al: Active
ascertainment of recurrence rate after treatment of primary basal
cell carcinoma (BCC). J Am Acad Dermatol. 73:323–325.
2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Tan CZ, Rieger KE and Sarin KY:
Basosquamous carcinoma: Controversy, advances, and future
directions. Dermatol Surg. 43:23–31. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wermker K, Roknic N, Goessling K, Klein M,
Schulze HJ and Hallermann C: Basosquamous carcinoma of the head and
neck: Clinical and histologic characteristics and their impact on
disease progression. Neoplasia. 17:301–305. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhu GA, Danial C, Liu A, Li S and Chang
AL: Overall and progression-free survival in metastatic
basosquamous cancer: A case series. J Am Acad Dermatol.
70:1145–1146. 2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Peris K, Fargnoli MC, Garbe C, Kaufmann R,
Bastholt L, Seguin NB, Bataille V, Marmol VD, Dummer R, Harwood CA,
et al: Diagnosis and treatment of basal cell carcinoma: European
consensus-based interdisciplinary guidelines. Eur J Cancer.
118:10–34. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ad Hoc Task Force. Connolly SM, Baker DR,
Coldiron BM, Fazio MJ, Storrs PA, Vidimos AT, Zalla MJ, Brewer JD,
Begolka WS, et al: AAD/ACMS/ASDSA/ASMS 2012 appropriate use
criteria for mohs micrographic surgery: A report of the American
academy of dermatology, American college of mohs surgery, American
society for dermatologic surgery association, and the American
society for mohs surgery. J Am Acad Dermatol. 67:531–550.
2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wetzig T, Woitek M, Eichhorn K, Simon JC
and Paasch U: Surgical excision of basal cell carcinoma with
complete margin control: Outcome at 5-year follow-up. Dermatology.
220:363–369. 2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Likhacheva A, Awan M, Barker CA, Bhatnagar
A, Bradfield L, Brady MS, Buzurovic I, Geiger JL, Parvathaneni U,
Zaky S and Devlin PM: Definitive and postoperative radiation
therapy for basal and squamous cell cancers of the skin: Executive
summary of an American society for radiation oncology clinical
practice guideline. Pract Radiat Oncol. 10:8–20. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Keohane SG, Proby CM, Newlands C, Motley
RJ, Nasr I and Mohd Mustapa MF: British Association of
Dermatologists (Squamous and Basal Cell Carcinoma Guideline
Development Groups). Slater DN: Royal College of Pathologists (Skin
Cancer Lead). The new 8th edition of TNM staging and its
implications for skin cancer: a review by the British Association
of Dermatologists and the Royal College of Pathologists, U.K. Br J
Dermatol. 179:824–828. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lomas A, Leonardi-Bee J and Bath-Hextall
F: A systematic review of worldwide incidence of nonmelanoma skin
cancer. Br J Dermatol. 166:1069–1080. 2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Verkouteren JAC, Ramdas KHR, Wakkee M and
Nijsten T: Epidemiology of basal cell carcinoma: Scholarly review.
Br J Dermatol. 177:359–372. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Solovastru LG, Vata D, Statescu L,
Constantin MM and Andrese E: Skin cancer between myth and reality,
yet ethically constrained. Rev Rom Bioet. 12:47–52. 2014.
|
|
18
|
Scrivener Y, Grosshans E and Cribier B:
Variations of basal cell carcinomas according to gender, age,
location and histopathological subtype. Br J Dermatol. 147:41–47.
2002.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Martin RC II, Edwards MJ, Cawte TG, Sewell
CL and McMasters KM: Basosquamous carcinoma: Analysis of prognostic
factors influencing recurrence. Cancer. 88:1365–1369.
2000.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Garcia C, Poletti E and Crowson AN:
Basosquamous carcinoma. J Am Acad Dermatol. 60:137–143.
2009.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Bowman PH, Ratz JL, Knoepp TG, Barnes CJ
and Finley EM: Basosquamous carcinoma. Dermatol Surg. 29:830–832.
2003.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Leibovitch I, Huilgol SC, Selva D,
Richards S and Paver R: Basosquamous carcinoma: Treatment with mohs
micrographic surgery. Cancer. 104:170–175. 2005.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Gallagher RP, Hill GB, Bajdik CD, Fincham
S, Coldman AJ, McLean DI and Threlfall WJ: Sunlight exposure,
pigmentary factors, and risk of nonmelanocytic skin cancer. I.
Basal cell carcinoma. Arch Dermatol. 131:157–163. 1995.PubMed/NCBI
|
|
24
|
Oldbury JW, Wain RAJ, Abas S, Dobson CM
and Iyer SS: Basosquamous carcinoma: A single centre
clinicopathological evaluation and proposal of an evidence-based
protocol. J Skin Cancer. 3(6061395)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Gulleth Y, Goldberg N, Silverman RP and
Gastman BR: What is the best surgical margin for a basal cell
carcinoma: A meta-analysis of the literature. Plast Reconstr Surg.
126:1222–1231. 2010.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Smeets NW, Krekels GA, Ostertag JU, Essers
BA, Dirksen CD, Nieman FH and Neumann HA: Surgical excision vs
Mohs' micrographic surgery for basal-cell carcinoma of the face:
Randomised controlled trial. Lancet. 364:1766–1772. 2004.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bath-Hextall F, Ozolins M, Armstrong SJ,
Colver GB, Perkins W, Miller PS and Williams HC: Surgery versus
Imiquimod for Nodular Superficial basal cell carcinoma (SINS) study
group. Surgical excision versus imiquimod 5% cream for nodular and
superficial basal-cell carcinoma (SINS): A multicentre,
non-inferiority, randomised controlled trial. Lancet Oncol.
15:96–105. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Love WE, Bernhard JD and Bordeaux JS:
Topical imiquimod or fluorouracil therapy for basal and squamous
cell carcinoma: A systematic review. Arch Dermatol. 145:1431–1438.
2009.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Voiculescu VM, Lisievici CV, Lupu M,
Vajaitu C, Draghici CC, Popa AV, Solomon I, Sebe TI, Constantin MM
and Caruntu C: Mediators of inflammation in topical therapy of skin
cancers. Mediators Inflamm. 10(8369690)2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Roozeboom MH, Arits AH, Nelemans PJ and
Kelleners-Smeets NW: Overall treatment success after treatment of
primary superficial basal cell carcinoma: A systematic review and
meta-analysis of randomized and nonrandomized trials. Br J
Dermatol. 167:733–756. 2012.PubMed/NCBI View Article : Google Scholar
|
